1. Home
  2. UBX vs NCRA Comparison

UBX vs NCRA Comparison

Compare UBX & NCRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UBX
  • NCRA
  • Stock Information
  • Founded
  • UBX 2009
  • NCRA 2002
  • Country
  • UBX United States
  • NCRA Taiwan
  • Employees
  • UBX N/A
  • NCRA N/A
  • Industry
  • UBX Biotechnology: Pharmaceutical Preparations
  • NCRA Farming/Seeds/Milling
  • Sector
  • UBX Health Care
  • NCRA Consumer Staples
  • Exchange
  • UBX Nasdaq
  • NCRA Nasdaq
  • Market Cap
  • UBX 20.4M
  • NCRA 16.8M
  • IPO Year
  • UBX 2018
  • NCRA N/A
  • Fundamental
  • Price
  • UBX $0.99
  • NCRA $0.99
  • Analyst Decision
  • UBX Strong Buy
  • NCRA
  • Analyst Count
  • UBX 3
  • NCRA 0
  • Target Price
  • UBX $5.33
  • NCRA N/A
  • AVG Volume (30 Days)
  • UBX 148.7K
  • NCRA 20.2K
  • Earning Date
  • UBX 04-22-2025
  • NCRA 05-14-2025
  • Dividend Yield
  • UBX N/A
  • NCRA N/A
  • EPS Growth
  • UBX N/A
  • NCRA N/A
  • EPS
  • UBX N/A
  • NCRA N/A
  • Revenue
  • UBX N/A
  • NCRA $20,483,694.00
  • Revenue This Year
  • UBX N/A
  • NCRA N/A
  • Revenue Next Year
  • UBX N/A
  • NCRA N/A
  • P/E Ratio
  • UBX N/A
  • NCRA N/A
  • Revenue Growth
  • UBX N/A
  • NCRA N/A
  • 52 Week Low
  • UBX $0.85
  • NCRA $0.70
  • 52 Week High
  • UBX $3.10
  • NCRA $2.09
  • Technical
  • Relative Strength Index (RSI)
  • UBX 37.79
  • NCRA 54.10
  • Support Level
  • UBX $0.91
  • NCRA $0.84
  • Resistance Level
  • UBX $1.07
  • NCRA $1.00
  • Average True Range (ATR)
  • UBX 0.09
  • NCRA 0.09
  • MACD
  • UBX 0.03
  • NCRA 0.00
  • Stochastic Oscillator
  • UBX 61.29
  • NCRA 86.24

About UBX Unity Biotechnology Inc.

Unity Biotechnology Inc designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells, and creating senolytic medicines. Its medicines target vulnerabilities to senescent cells to clear those cells from the human body while leaving normal cells unaffected. The firm focuses on age-associated diseases such as osteoarthritis, eye diseases, and pulmonary diseases. Its drug candidates include, UBX1325 is being developed for age-related diseases of the eye, including diabetic macular edema, or DME, UBX2089, which is a circulating hormone which is produced in the kidneys and choroid plexus of the brain, which is being researched for multiple neurology indications, and UBX2050.

About NCRA Nocera Inc.

Nocera Inc is engaged in the manufacturing of aquaculture equipment, construction of aquaculture facilities, managing and operating aquaculture facilities, and consulting for third-party operators of aquaculture facilities. Its primary business operations consist of the design, development, and production of RASs large-scale fish tank systems, for fish farms along with expert consulting, technology transfer, and aquaculture project management services to new and existing aquaculture management business services.

Share on Social Networks: